000 01367 a2200397 4500
005 20250517163403.0
264 0 _c20180507
008 201805s 0 0 eng d
022 _a1471-6348
024 7 _a10.1017/S0266462317000332
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRussi, Alberto
245 0 0 _aCASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.
_h[electronic resource]
260 _bInternational journal of technology assessment in health care
_cJan 2017
300 _a199-205 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIpilimumab
_xeconomics
650 0 4 _aItaly
650 0 4 _aMale
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aRetrospective Studies
650 0 4 _aSkin Neoplasms
_xdrug therapy
700 1 _aChiarion-Sileni, Vanna
700 1 _aDamuzzo, Vera
700 1 _aDi Sarra, Francesca
700 1 _aPigozzo, Jacopo
700 1 _aPalozzo, Angelo Claudio
773 0 _tInternational journal of technology assessment in health care
_gvol. 33
_gno. 2
_gp. 199-205
856 4 0 _uhttps://doi.org/10.1017/S0266462317000332
_zAvailable from publisher's website
999 _c27363203
_d27363203